- $926.25m
- $1.67bn
- $691.12m
- 63
- 85
- 28
- 59
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 533 | 496 | 611 | 820 | 691 |
Cost of Revenue | |||||
Gross Profit | 167 | 151 | 177 | 225 | 198 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 470 | 469 | 583 | 716 | 594 |
Operating Profit | 62.6 | 26.5 | 27.7 | 104 | 96.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 43.4 | 2.21 | 13.9 | 94.7 | 81.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 31.1 | 54.3 | 1.79 | 69.8 | 71.2 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 79.5 | -279 | -140 | 73.7 | 71.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 79.5 | -279 | -140 | 73.7 | 71.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.284 | 0.558 | 0.194 | 0.637 | 0.666 |
Special Dividends per Share |